IP Library Granted Patent US 9,068,004
Granted Patent B2
US 9,068,004 · App. 13/576,838 · Granted Jun 30, 2015

TWEAK/Fn14 system regulates skeletal muscle atrophy and regeneration

Inventor: Ashok Kumar (Louisville, KY)
Assignee: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
C07K16/2875A61K2039/505
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,068,004
App. No.
13/576,838
Granted
Jun 30, 2015
Kind
B2
Abstract

The invention provides methods for preventing loss and augmenting regeneration of skeletal muscle by decreasing the activity of the TWEAK/Fn14 system.

Claims (17)

1. A method for reducing loss of skeletal muscle in a patient having a battlefield injury, an accidental injury, cancer, anorexia or diabetes, comprising administering to a patient having a battlefield injury, an accidental injury, cancer, anorexia or diabetes a therapeutically effective amount of an agent that decreases the activity of the TWEAK/Fn14 system so as to reduce the loss of skeletal muscle, wherein the agent is a TWEAK neutralizing antibody that blocks TWEAK activity.

2. The method of claim 1 , wherein the patient has a battlefield or accidental injury.

3. The method of claim 2 , wherein the patient has a battlefield injury.

4. The method of claim 1 , wherein the patient has cancer.

5. The method of claim 1 , wherein the patient has anorexia.

6. The method of claim 1 , wherein the patient has diabetes.

7. The method of claim 6 , wherein the patient has type II diabetes.

8. The method of claim 1 , wherein the skeletal muscle is a soleus, tibial anteriors, gastrocnemius, EDL, diaphragm, biceps, triceps, quadriceps, facial, tongue, or abdominal muscle.

9. The method of claim 1 , wherein the administration of the therapeutically effective amount of an agent that decreases the activity of the TWEAK/Fn14 system also reduces the loss of force production by the skeletal muscle.

10. A method for reducing loss of force production by skeletal muscle in a patient having a battlefield injury, an accidental injury, cancer, anorexia or diabetes, comprising administering to a patient having a battlefield injury, an accidental injury, cancer, anorexia or diabetes a therapeutically effective amount of an agent that decreases the activity of the TWEAK/Fn14 system so as to reduce the loss of force production by the skeletal muscle, wherein the agent is a TWEAK neutralizing antibody that blocks TWEAK activity.

11. The method of claim 10 , wherein the patient has a battlefield or accidental injury.

12. The method of claim 11 , wherein the patient has a battlefield injury.

13. The method of claim 10 , wherein the patient has cancer.

14. The method of claim 10 , wherein the patient has anorxia.

15. The method of claim 10 , wherein the patient has diabetes.

16. The method of claim 15 , wherein the patient has type II diabetes.

17. The method of claim 10 , wherein the skeletal muscle is a soleus, tibial anteriors, gastrocnemius, EDL, diaphragm, biceps, triceps, quadriceps, facial, tongue, or abdominal muscle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: KUMAR, ASHOK
To: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
Reel/Frame 029837/0814 →
CONFIRMATORY LICENSE Recorded Sep 6, 2012
From: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028918/0025 →
Continuity (2)
Provisional Application 61301454 · Feb 4, 2010
Related Publication 20130028912A1 · Jan 31, 2013